Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 3
2005 1
2006 2
2007 3
2008 2
2009 1
2010 1
2011 1
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Bidard FC, Hardy-Bessard AC, Dalenc F, Bachelot T, Pierga JY, de la Motte Rouge T, Sabatier R, Dubot C, Frenel JS, Ferrero JM, Ladoire S, Levy C, Mouret-Reynier MA, Lortholary A, Grenier J, Chakiba C, Stefani L, Plaza JE, Clatot F, Teixeira L, D'Hondt V, Vegas H, Derbel O, Garnier-Tixidre C, Canon JL, Pistilli B, André F, Arnould L, Pradines A, Bièche I, Callens C, Lemonnier J, Berger F, Delaloge S; PADA-1 investigators. Bidard FC, et al. Lancet Oncol. 2022 Nov;23(11):1367-1377. doi: 10.1016/S1470-2045(22)00555-1. Epub 2022 Sep 29. Lancet Oncol. 2022. PMID: 36183733 Clinical Trial.
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
Berger F, Marce M, Delaloge S, Hardy-Bessard AC, Bachelot T, Bièche I, Pradines A, De La Motte Rouge T, Canon JL, André F, Arnould L, Clatot F, Lemonnier J, Marques S, Bidard FC; PADA-1 investigators. Berger F, et al. BMJ Open. 2022 Mar 3;12(3):e055821. doi: 10.1136/bmjopen-2021-055821. BMJ Open. 2022. PMID: 35241469 Free PMC article. Clinical Trial.
Metastatic melanoma: chemotherapy.
Bajetta E, Del Vecchio M, Bernard-Marty C, Vitali M, Buzzoni R, Rixe O, Nova P, Aglione S, Taillibert S, Khayat D. Bajetta E, et al. Among authors: bernard marty c. Semin Oncol. 2002 Oct;29(5):427-45. doi: 10.1053/sonc.2002.35238. Semin Oncol. 2002. PMID: 12407508 Review.
Chemobrain: is systemic chemotherapy neurotoxic?
Taillibert S, Voillery D, Bernard-Marty C. Taillibert S, et al. Among authors: bernard marty c. Curr Opin Oncol. 2007 Nov;19(6):623-7. doi: 10.1097/CCO.0b013e3282f0e224. Curr Opin Oncol. 2007. PMID: 17906463 Review.
Adjuvant chemotherapy in 2005: standards and beyond.
Piccart MJ, de Valeriola D, Dal Lago L, de Azambuja E, Demonty G, Lebrun F, Bernard-Marty Ch, Colozza M, Cufer T. Piccart MJ, et al. Among authors: bernard marty ch. Breast. 2005 Dec;14(6):439-45. doi: 10.1016/j.breast.2005.08.004. Epub 2005 Sep 26. Breast. 2005. PMID: 16188441 Review.
Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review.
Gérard S, Bréchemier D, Lefort A, Lozano S, Abellan Van Kan G, Filleron T, Mourey L, Bernard-Marty C, Rougé-Bugat ME, Soler V, Vellas B, Cesari M, Rolland Y, Balardy L. Gérard S, et al. Among authors: bernard marty c. J Nutr Health Aging. 2016;20(8):878-888. doi: 10.1007/s12603-015-0653-2. J Nutr Health Aging. 2016. PMID: 27709238 Free article. Review.
Management of head and neck cancer in elderly patients.
Lalami Y, de Castro G Jr, Bernard-Marty C, Awada A. Lalami Y, et al. Among authors: bernard marty c. Drugs Aging. 2009;26(7):571-83. doi: 10.2165/11316340-000000000-00000. Drugs Aging. 2009. PMID: 19655824 Review.
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper.
Aapro M, Bernard-Marty C, Brain EG, Batist G, Erdkamp F, Krzemieniecki K, Leonard R, Lluch A, Monfardini S, Ryberg M, Soubeyran P, Wedding U. Aapro M, et al. Among authors: bernard marty c. Ann Oncol. 2011 Feb;22(2):257-67. doi: 10.1093/annonc/mdq609. Epub 2010 Oct 18. Ann Oncol. 2011. PMID: 20956616 Free article. Review.
26 results